Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia.
Hsu Y-HH., Pintacuda G., Liu R., Nacu E., Kim A., Tsafou K., Petrossian N., Crotty W., Suh JM., Riseman J., Martin JM., Biagini JC., Mena D., Ching JKT., Malolepsza E., Li T., Singh T., Ge T., Egri SB., Tanenbaum B., Stanclift CR., Apffel AM., Schizophrenia Working Group of the Psychiatric Genomics Consortium None., Stanley Global Asia Initiatives None., Carr SA., Schenone M., Jaffe J., Fornelos N., Huang H., Eggan KC., Lage K.
Genetics have nominated many schizophrenia risk genes and identified convergent signals between schizophrenia and neurodevelopmental disorders. However, functional interpretation of the nominated genes in the relevant brain cell types is often lacking. We executed interaction proteomics for six schizophrenia risk genes that have also been implicated in neurodevelopment in human induced cortical neurons. The resulting protein network is enriched for common variant risk of schizophrenia in Europeans and East Asians, is down-regulated in layer 5/6 cortical neurons of individuals affected by schizophrenia, and can complement fine-mapping and eQTL data to prioritize additional genes in GWAS loci. A sub-network centered on HCN1 is enriched for common variant risk and contains proteins (HCN4 and AKAP11) enriched for rare protein-truncating mutations in individuals with schizophrenia and bipolar disorder. Our findings showcase brain cell-type-specific interactomes as an organizing framework to facilitate interpretation of genetic and transcriptomic data in schizophrenia and its related disorders.